NO984458L - Transdermalt terapeutisk system med liten applikasjons-omrÕdetykkelse og stor fleksibilitet og fremgangsmÕte - Google Patents

Transdermalt terapeutisk system med liten applikasjons-omrÕdetykkelse og stor fleksibilitet og fremgangsmÕte

Info

Publication number
NO984458L
NO984458L NO984458A NO984458A NO984458L NO 984458 L NO984458 L NO 984458L NO 984458 A NO984458 A NO 984458A NO 984458 A NO984458 A NO 984458A NO 984458 L NO984458 L NO 984458L
Authority
NO
Norway
Prior art keywords
layer
transdermal therapeutic
therapeutic system
application area
great flexibility
Prior art date
Application number
NO984458A
Other languages
English (en)
Other versions
NO984458D0 (no
Inventor
Reinhard Von Kleinsorgen
Britta Von Kleinsorgen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19708674A external-priority patent/DE19708674C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO984458D0 publication Critical patent/NO984458D0/no
Publication of NO984458L publication Critical patent/NO984458L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Et transdermalt terapeutisk system for avgivelse av aktivstoffer til et substrat er karakterisert ved sammensetningen av systemet av et bæresjikt (1) forsynt med et skillesjikt (2), et filmsjikt (3) som inneholder aktivstoffet, og et abhesivt utrustet beskyttelsessjikt (4), hvorved skillesjiktet (2) består av et materiale hvis forbindelse med filmsjiktet (3) kan oppheves. Trykketeknisk lar slike systemer seg fremstille med liten applikasjonstykkelse og høy fleksibilitet, hvorved det kan forutses et abhesivt utrustet substrat som alternativ til bære/ skillesjiktkomplekset. En trykkefremgangsmåte som begrenser det aktivstoff- holdige område på applikasjonsflaten minsker miljøproblemene.
NO984458A 1996-03-25 1998-09-24 Transdermalt terapeutisk system med liten applikasjons-omrÕdetykkelse og stor fleksibilitet og fremgangsmÕte NO984458L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19611684 1996-03-25
DE19708674A DE19708674C2 (de) 1996-03-25 1997-03-04 Transdermales therapeutisches System mit einer wirkstoffhaltigen Filmschicht und einer löslichen Trennschicht, sowie ein Verfahren zu dessen Herstellung
PCT/EP1997/001252 WO1997035564A1 (de) 1996-03-25 1997-03-12 Transdermales therapeutisches system mit geringer applikationsdicke und hoher flexibilität sowie herstellungsverfahren

Publications (2)

Publication Number Publication Date
NO984458D0 NO984458D0 (no) 1998-09-24
NO984458L true NO984458L (no) 1998-11-24

Family

ID=26024096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984458A NO984458L (no) 1996-03-25 1998-09-24 Transdermalt terapeutisk system med liten applikasjons-omrÕdetykkelse og stor fleksibilitet og fremgangsmÕte

Country Status (17)

Country Link
US (1) US6165499A (no)
EP (1) EP0889723B1 (no)
JP (1) JP4086317B2 (no)
CN (1) CN1219126A (no)
AT (1) ATE218328T1 (no)
AU (1) AU728120B2 (no)
CZ (1) CZ306398A3 (no)
DK (1) DK0889723T3 (no)
ES (1) ES2177962T3 (no)
HU (1) HUP9902673A3 (no)
IL (1) IL126251A (no)
NO (1) NO984458L (no)
NZ (1) NZ332033A (no)
PL (1) PL329196A1 (no)
PT (1) PT889723E (no)
SK (1) SK130298A3 (no)
WO (1) WO1997035564A1 (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
DE29823343U1 (de) * 1998-03-20 1999-07-15 Schwarz Pharma Ag, 40789 Monheim Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
DE19826592A1 (de) * 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
KR100594666B1 (ko) * 1999-03-18 2006-07-03 에르테에스 로만 테라피-시스테메 아게 경피적 치료 시스템 및 그 제조방법
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
DE19954420A1 (de) * 1999-11-12 2001-05-31 Lohmann Therapie Syst Lts Zubereitung, bestehend aus einer film-, folien- oder oblatenförmigen Darreichungsform mit zweischichtigem Aufbau und integrierter Kennzeichnung
US6783294B2 (en) 2000-02-14 2004-08-31 Johnson & Johnson Consumer Companies, Inc. Solid cleanser holder
US6607739B1 (en) 2000-02-14 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Dispensing article
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
KR20020035398A (ko) * 2000-11-06 2002-05-11 김윤 수지(手指)용 진통 소염 경피투여제
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
EP1390085B1 (en) 2001-05-01 2009-08-05 A.V. Topchiev Institute of Petrochemical Synthesis Hydrogel compositions
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US6803420B2 (en) 2001-05-01 2004-10-12 Corium International Two-phase, water-absorbent bioadhesive composition
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2449293A1 (en) * 2001-06-18 2002-12-27 The Procter & Gamble Company Cosmetic compositions comprising discrete color domains and associated methods
US20030003065A1 (en) * 2001-06-18 2003-01-02 The Procter & Gamble Company Cosmetic compositions exhibiting characteristic first derivative spectral curves and associated methods
US20030054025A1 (en) * 2001-09-14 2003-03-20 3M Innovative Properties Company Non-contact printing method for making a medical pressure sensitive adhesive article
US20030097111A1 (en) * 2001-11-08 2003-05-22 Catarina Lundin Absorbent product
JP2005528359A (ja) * 2002-03-20 2005-09-22 ユーロ−セルティーク エス．エイ． うつ病の治療のためのブプレノルフィンの投与方法
EP1795189A3 (en) * 2002-03-20 2007-08-15 Euro-Celtique S.A. Method of administering buprenorphine to treat depression
GB0213437D0 (en) * 2002-06-12 2002-07-24 Univ Cranfield Temporary tattoos: A novel vehicle for skin testing
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
CA2522529C (en) 2003-04-30 2015-10-20 Purdue Pharma L.P. Tamper resistant transdermal dosage form
EP1498133A1 (en) 2003-07-18 2005-01-19 Aventis Pharma Deutschland GmbH Use of a pak inhibitor for the treatment of a joint disease
CA2524122C (en) * 2003-07-25 2010-11-16 Lts Lohmann Therapie-Systeme Ag Wafer fixing and marking
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
EP1531333A1 (en) 2003-11-12 2005-05-18 Aventis Pharma Deutschland GmbH Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
AU2005210637B2 (en) 2004-01-30 2010-09-16 A.V. Topchiev Institute Of Petrochemical Synthesis Rapidly dissolving film for delivery of an active agent
EP1602365A1 (en) * 2004-03-03 2005-12-07 Switch Biotech Aktiengesellschaft Pharmaceutical composition for topical use in form of xerogels or films and methods for production
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
EP1740617B1 (en) 2004-04-23 2013-10-16 BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
US20050281757A1 (en) * 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
CA2576158C (en) 2004-08-05 2020-10-27 Corium International, Inc. Adhesive composition
AU2006222204B2 (en) 2005-03-11 2012-09-27 Sanofi-Aventis Use of MGC4504
US20060222693A1 (en) * 2005-03-30 2006-10-05 Silguero Kandy M Transdermal patch bearing a decorative image
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
DE102005048898A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
RU2008124805A (ru) * 2005-11-21 2009-12-27 Шеринг-Плоу Лтд. (CH) Фармацевтические композиции, содержащие бупренорфин
EP1795609A1 (en) 2005-12-06 2007-06-13 Sanofi-Aventis Deutschland GmbH Method for the diagnosis and treatment of cardiovascular diseases
US20090208545A1 (en) * 2008-02-20 2009-08-20 Carter-Lyde Nicole B System and method for providing medicinal treatment
EP2105742A1 (en) 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
AU2009264237B2 (en) 2008-06-27 2016-04-14 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
EP2293072A1 (en) 2009-08-31 2011-03-09 Sanofi-Aventis Use of cathepsin H
TW201239097A (en) 2010-12-17 2012-10-01 Sanofi Sa MiRNAs in joint disease
TW201238974A (en) 2010-12-17 2012-10-01 Sanofi Sa MiRNAs in joint disease
TW201241179A (en) 2010-12-17 2012-10-16 Sanofi Sa MiRNAs in joint disease
UY33807A (es) 2010-12-17 2012-07-31 Sanofi Sa miRNAs como indicadores del estado tisular o de enfermedades como osteoartritis
EP2578088A1 (en) 2011-10-06 2013-04-10 Nestec S.A. Edible web comprising microorganisms
AU2012385956B2 (en) 2012-07-23 2017-03-30 Crayola, Llc Dissolvable films and methods of using the same
JP2017510474A (ja) * 2013-12-31 2017-04-13 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド インテグラルフィルム製品を形成するための方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637224A (en) * 1969-02-27 1972-01-25 Fedders Corp Annular sealing ring
DE2908432A1 (de) * 1979-03-05 1980-09-11 Volkswagenwerk Ag Waermepumpen-antriebsaggregat mit einem kompressor und einer brennkraftmaschine
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
CH674618A5 (no) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
CA2078961A1 (en) * 1992-04-21 1993-10-22 John Wick Two-hand pouch patch application
DE69625549T2 (de) * 1995-06-27 2003-05-15 Kao Corp., Tokio/Tokyo Pflaster mit wasserlöslicher Klebeschicht
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use

Also Published As

Publication number Publication date
AU728120B2 (en) 2001-01-04
DK0889723T3 (da) 2002-09-23
ATE218328T1 (de) 2002-06-15
HUP9902673A3 (en) 2001-04-28
JP4086317B2 (ja) 2008-05-14
NZ332033A (en) 1999-09-29
NO984458D0 (no) 1998-09-24
PT889723E (pt) 2002-11-29
SK130298A3 (en) 1999-03-12
JP2002504084A (ja) 2002-02-05
AU2155597A (en) 1997-10-17
WO1997035564A1 (de) 1997-10-02
ES2177962T3 (es) 2002-12-16
EP0889723A1 (de) 1999-01-13
HUP9902673A2 (hu) 2000-10-28
CZ306398A3 (cs) 1999-01-13
IL126251A (en) 2003-06-24
IL126251A0 (en) 1999-05-09
EP0889723B1 (de) 2002-06-05
PL329196A1 (en) 1999-03-15
US6165499A (en) 2000-12-26
CN1219126A (zh) 1999-06-09

Similar Documents

Publication Publication Date Title
NO984458L (no) Transdermalt terapeutisk system med liten applikasjons-omrÕdetykkelse og stor fleksibilitet og fremgangsmÕte
PT941078E (pt) Metodo e dispositivo para o revestimento de substratos para utilizacao farmaceutica
AU694984B2 (en) Composition for the controlled release of active substances
DE59108962D1 (de) Pflaster mit hohem Gehalt an weichmachenden Inhaltsstoffen
CA2177970A1 (en) Plaster containing an active substance
ES2023640B3 (es) Sustrato para soportar polvos abrasivos adheridos y metodo para formar el sustrato y el material adhesivo.
FI97779C (fi) Käsikoje kalvon siirtämiseen taustakalvolta alustalle
MY110531A (en) Plaster for the transdermal application of steroid hormones, containing dexpanthenol
JPS55165172A (en) Applying method for substrate
MY113919A (en) Layered tablet for the controlled release of active substances
AU5314786A (en) Carrier for immobilising biologically active organic material
EP0905564A3 (en) Dry film photoresist construction suitable for rolling up on itself
CA2250025A1 (en) Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
DK0865274T3 (da) Overfladestabiliseret, farmaceutisk præparat til påføring af huden
AR016641A1 (es) Materiales en hojas absorbentes y de proteccion de multiples aplicaciones
JPS52130979A (en) Immobilization of glucoseisomerase
AU5765398A (en) Removable protective film for plaster systems, in particular self-adhesive plaster systems, containing active substances

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application